Title:
ＰＤ－１標的化ＩＬ－２変異体イムノコンジュゲートとＦＡＰ／４－１ＢＢ結合分子との併用療法
Document Type and Number:
Japanese Patent JP2024508949
Kind Code:
A
Abstract:
本発明は、特異的ＰＤ－１標的化ＩＬ－２変異体イムノコンジュゲートと、ヒトＦＡＰおよび４－１ＢＢに結合する特異的抗体との、および任意選択で抗ＣＥＡ／抗ＣＤ３二重特異性抗体との、併用療法に関する。【選択図】なし
More Like This:
Inventors:
Bakak, Marina
Klaus, Christina
Kodallideek, Laura
Colombetti, Sarah
Klein, Christian
Nicolini, Valeria Gee.
Pero, Mario
Sam, Johannes
Trump Feller, Christine
Umagna, Pablo
Klaus, Christina
Kodallideek, Laura
Colombetti, Sarah
Klein, Christian
Nicolini, Valeria Gee.
Pero, Mario
Sam, Johannes
Trump Feller, Christine
Umagna, Pablo
Application Number:
JP2023554306A
Publication Date:
February 28, 2024
Filing Date:
March 08, 2022
Export Citation:
Assignee:
Ef Hoffman-La Roche Akchengezel Shaft
International Classes:
C07K19/00; A61K35/17; A61K38/20; A61K39/00; A61K39/395; A61K47/55; A61K47/68; A61P1/02; A61P1/04; A61P1/16; A61P1/18; A61P11/00; A61P11/02; A61P11/04; A61P13/08; A61P13/10; A61P13/12; A61P15/00; A61P17/00; A61P35/00; A61P35/02; A61P35/04; A61P43/00; C07K16/46; C12N15/26
Attorney, Agent or Firm:
Sonoda & Kobayashi Patent Attorneys Corporation